Press Release: Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress

Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress Halle (Saale) / Munich, Germany, May 16, 2023 - Vivoryon Therapeutics N.V. (Euronext

Related Keywords

Netherlands ,Amsterdam ,Noord Holland ,Germany ,Dinnies Johannes ,Morten Asser Karsdal ,Ulrich Dauer ,Kugan Sathiyanandarajah ,Corporate Development ,Company Annual ,Varoglutamstat Clinical Program ,International Conference On Alzheimer ,Press Release ,Highlights Operational Progress ,Euronext Amsterdam ,Post Period Portfolio Highlights ,Clinical Program ,Development Highlights ,Reflecting Vivoryon ,Professor Morten Asser Karsdal ,Non Executive Board ,Annual General ,Annual Report ,Dow Jones Newswires ,Gefallene Big Techs ,Vivoryon ,Herapeutics ,Reports ,023 ,Financial ,Results ,Highlights ,Perational ,Progress ,